| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Kory Jasperson | |
| Amanda Gammon | |||
| Marjan Champine | |||
| P2860 | cites work | Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients | Q21198716 |
| PTEN mosaicism with features of Cowden syndrome | Q85653551 | ||
| A case of Cowden's syndrome presenting with gastric carcinomas and gastrointestinal polyposis | Q50180967 | ||
| Should patients with Cowden syndrome undergo prophylactic thyroidectomy? | Q50303885 | ||
| Endometrial cancer in a 14-year-old girl with Cowden syndrome: a case report. | Q51283622 | ||
| Evaluation of germline PTEN mutations in endometrial cancer patients | Q56928438 | ||
| BeyondBRCA1andBRCA2wild-type breast and/or ovarian cancer families: germline mutations inTP53andPTEN | Q57083821 | ||
| First Report of Ovarian Dysgerminoma in Cowden Syndrome with Germline PTEN Mutation and PTEN-related 10q Loss of Tumor Heterozygosity | Q57590980 | ||
| Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas | Q57591220 | ||
| Localization of the gene for Cowden disease to chromosome 10q22–23 | Q57694734 | ||
| Endometrial Cancer in an Adolescent | Q60167344 | ||
| The Cowden syndrome: a clinical and genetic study in 21 patients | Q69486172 | ||
| Multiple hamartoma syndrome presenting with oral lesions | Q71712580 | ||
| Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies | Q73722520 | ||
| Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families | Q80629440 | ||
| Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity | Q83054848 | ||
| Cowden syndrome | Q84877384 | ||
| Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome | Q85229853 | ||
| Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model | Q22337253 | ||
| P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 | ||
| A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands | Q24606333 | ||
| Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes | Q24649528 | ||
| Will the real Cowden syndrome please stand up: revised diagnostic criteria | Q24681567 | ||
| Cowden's disease. A possible new symptom complex with multiple system involvement | Q28189705 | ||
| Male breast cancer in Cowden syndrome patients with germline PTEN mutations | Q28359884 | ||
| Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome | Q29615538 | ||
| Germline Inactivation of PTEN and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway Cause Human Lhermitte-Duclos Disease in Adults | Q33905657 | ||
| Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations | Q34173563 | ||
| Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer | Q34321254 | ||
| Frequency of germline PTEN mutations in differentiated thyroid cancer | Q34975154 | ||
| The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases. | Q35250021 | ||
| Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations | Q35597950 | ||
| Lifetime cancer risks in individuals with germline PTEN mutations. | Q35681689 | ||
| Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53. | Q35747115 | ||
| Upper and Lower Gastrointestinal Findings in PTEN Mutation-Positive Cowden Syndrome Patients Participating in an Active Surveillance Program | Q36002740 | ||
| Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome | Q36837037 | ||
| Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers | Q36839671 | ||
| Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome | Q36847856 | ||
| Do you know this syndrome? | Q37233793 | ||
| PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing? | Q37247172 | ||
| Cowden syndrome: a critical review of the clinical literature | Q37313091 | ||
| Cognitive characteristics of PTEN hamartoma tumor syndromes | Q37640770 | ||
| Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps | Q37671215 | ||
| Cutaneous manifestations of gastrointestinal disease: part I. | Q38073970 | ||
| Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria | Q38153670 | ||
| Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study | Q39693657 | ||
| Cowden's disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature | Q40272335 | ||
| Novel mutation identified in Cowden syndrome presenting as a gastric adenocarcinoma | Q44070914 | ||
| High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome | Q44636065 | ||
| A mosaic PTEN mutation causing Cowden syndrome identified by deep sequencing | Q44947400 | ||
| Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation | Q45345194 | ||
| Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features | Q46077160 | ||
| Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin | Q46403725 | ||
| Brain magnetic resonance imaging in patients with Cowden syndrome | Q48974595 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 83-92 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | The Application of Clinical Genetics | Q15817525 |
| P1476 | title | Genetic basis of Cowden syndrome and its implications for clinical practice and risk management | |
| P478 | volume | 9 |
| Q57646614 | Early Onset Multiple Primary Tumors in Atypical Presentation of Cowden Syndrome Identified by Whole-Exome-Sequencing |
| Q54893685 | Facial papules as a marker of cancer predisposition syndrome. |
| Q47899152 | Lhermitte-Duclos Disease (Dysplastic Gangliocytoma of the Cerebellum) and Cowden Syndrome: Clinical Experience From a Single Institution with Long-Term Follow-Up |
| Q39110230 | Lhermitte-Duclos disease associated to Cowden syndrome: de novo diagnosis and management of these extremely rare syndromes in a patient. |
| Q90139197 | Mosaicism in Patients With Colorectal Cancer or Polyposis Syndromes: a Systematic Review |
| Q46546002 | The PI3K Pathway in Human Disease |
Search more.